Betamethasone acetate plus phosphate vs betamethasone phosphate – fetal/neonatal outcomes
Respiratory distress syndrome · women at risk of preterm birth
It is very uncertain whether betamethasone acetate plus phosphate changes respiratory distress syndrome compared with betamethasone phosphate – fetal/neonatal outcomes (very low certainty).
1 finding from 1 review
- Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth 2022 · Cochrane Headline outcomes onlyRR 0.19 [0.01, 3.91]1 study · 69 participantsVery low